As evidenced by recent publication, a 35-year-old man with stable cystic fibrosis, not on CFTR modulators, was found to have ALK-translocated lung cancer after presenting with an assumed bacterial exacerbation. The gene discussed is CFTR; the disease is lung carcinoma.